Our "New in MDS" articles cover treatment option updates, coverage of advancements from MDS academic meetings, and more.
May 23, 2023
For more than 30 years, umbilical cord blood (UCB) has been an important stem cell source for patients with leukemia, lymphoma and MDS
May 02, 2023
Dr. Sekeres shared with us what he and his MDS colleagues are focusing their research on right now.
April 25, 2023
Dr. Chandhok is doing important research into improving drug efficacy for underserved populations.
April 18, 2023
The work Dr. Tinsley Vance is doing is important and will have a big impact on the way we look at patient decision making and our support of caregivers.
April 04, 2023
Immune system regulators are emerging as significant targets for immunotherapy in hematological malignancies.
March 07, 2023
BMT “was associated with an increased risk of subsequent malignant neoplasms of the gastrointestinal (GI) tract.”
January 31, 2023
During the 64th ASH Annual Meeting, Dr. Verma outlined the various inflammatory mediators that are elevated in MDS.
January 25, 2023
Venetoclax is a BCL-2 inhibitor, meaning it blocks the action of the BCL-2 protein that helps cancer cells survive and grow.
January 18, 2023
Many factors contribute to health inequity including access to care and health insurance, cost, and education